We are live on
!
Find out more
EI
EAM Investors Portfolio holdings
AUM
$866M
1-Year Est. Return
377.14%
This Fund
S&P 500
This Quarter
Est. Return
+47.43%
1 Year Est. Return
+377.14%
3 Year Est. Return
+5,228.32%
5 Year Est. Return
+49,813.17%
10 Year Est. Return
+19,957,666.26%
AUM
$540M
AUM Growth
+$30.8M
(+6%)
Cap. Flow
-$71M
Cap. Flow
% of AUM
-13.15%
Top 10 Holdings %
Top 10 Hldgs %
9.77%
Holding
405
New
161
Increased
21
Reduced
59
Closed
149
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Applied Digital
APLD
|
+$4.62M |
| 2 |
WW
WW International
WW
|
+$3.97M |
| 3 |
Harmonic Inc
HLIT
|
+$3.58M |
| 4 |
SI-BONE Inc
SIBN
|
+$3.34M |
| 5 |
Tactile Systems Technology
TCMD
|
+$2.91M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Viking Therapeutics
VKTX
|
+$5.66M |
| 2 |
Harrow
HROW
|
+$5.57M |
| 3 |
Impinj
PI
|
+$5.06M |
| 4 |
Ceco Environmental
CECO
|
+$4.79M |
| 5 |
Par Pacific Holdings
PARR
|
+$4.38M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 26.89% |
| 2 | Technology | 25.18% |
| 3 | Industrials | 23.68% |
| 4 | Consumer Discretionary | 11.94% |
| 5 | Consumer Staples | 3.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Vaxcyte
PCVX
$7.9B
| $3.02M | 0.56% |
60,554
+10,691
| +21% | +$507K |
|
52
Atlanta Braves Holdings Series A
BATRA
$3.52B
| $3M | 0.56% |
+74,917
| New | +$2.9M |
|
53
Avita Medical
RCEL
$142M
| $2.96M | 0.55% |
173,756
-81,268
| -32% | -$1.19M |
|
54
Urban Outfitters
URBN
$6.75B
| $2.94M | 0.54% |
+88,677
| New | +$2.59M |
|
55
IonQ
IONQ
$15.6B
| $2.93M | 0.54% |
+216,686
| New | +$1.8M |
|
56
e.l.f. Beauty
ELF
$5.18B
| $2.91M | 0.54% |
25,466
-8,813
| -26% | -$848K |
|
57
Credo Technology Group
CRDO
$44.4B
| $2.91M | 0.54% |
+167,585
| New | +$1.99M |
|
58
Veeco
VECO
$3.28B
| $2.87M | 0.53% |
+111,647
| New | +$2.45M |
|
59
Evolv Technologies
EVLV
$1.08B
| $2.86M | 0.53% |
+476,422
| New | +$2.25M |
|
|
NPKI
60
NPK International
NPKI
$1.16B
| $2.84M | 0.53% |
542,587
+456,856
| +533% | +$1.89M |
|
61
ACV Auctions
ACVA
$1.4B
| $2.83M | 0.52% |
+163,680
| New | +$2.5M |
|
62
Primoris Services
PRIM
$4.93B
| $2.82M | 0.52% |
+92,689
| New | +$2.48M |
|
63
OSI Systems
OSIS
$3.9B
| $2.82M | 0.52% |
+23,950
| New | +$2.75M |
|
|
GMS
64
DELISTED
GMS Inc
GMS
| $2.78M | 0.52% |
+40,188
| New | +$2.48M |
|
65
CarGurus
CARG
$3.34B
| $2.77M | 0.51% |
+122,573
| New | +$2.32M |
|
66
Super Micro Computer
SMCI
$20.5B
| $2.73M | 0.51% |
109,410
-65,340
| -37% | -$1.09M |
|
|
SCPH
67
DELISTED
scPharmaceuticals
SCPH
| $2.71M | 0.5% |
265,528
+96,207
| +57% | +$1M |
|
68
BridgeBio Pharma
BBIO
$16.1B
| $2.66M | 0.49% |
154,391
| – | – |
|
69
NVE Corp
NVEC
$618M
| $2.65M | 0.49% |
27,192
+5,452
| +25% | +$473K |
|
70
Quanterix
QTRX
$175M
| $2.63M | 0.49% |
+116,562
| New | +$2.08M |
|
71
Biohaven
BHVN
$2.07B
| $2.63M | 0.49% |
+109,841
| New | +$1.89M |
|
72
John B. Sanfilippo & Son
JBSS
$986M
| $2.6M | 0.48% |
22,190
-5,042
| -19% | -$565K |
|
73
Emcor
EME
$36.2B
| $2.57M | 0.48% |
13,909
-1,862
| -12% | -$311K |
|
74
Onto Innovation
ONTO
$14.3B
| $2.56M | 0.47% |
+21,993
| New | +$2.1M |
|
75
Sterling Infrastructure
STRL
$16.6B
| $2.56M | 0.47% |
45,806
-51,469
| -53% | -$2.28M |
|
Similar funds
RWM
MCM
HP
OMG
RB
ICCFIA
WCM
TSS
EAM Investors's Q2 2023 Portfolio in Review
As of Q2 2023, EAM Investors held 405 positions worth $540M, up 6% from $509M the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.
EAM Investors withdrew a net $71M in Q2 2023, closing 149 positions and reducing 59 holdings. Its most notable exit was Viking Therapeutics, an estimated $5.66M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 27% of assets, up from 25% a quarter earlier, followed by Technology and Industrials.
Against the trend, EAM Investors opened a new position in Applied Digital worth $7.24M.
- EAM Investors's largest Q2 2023 buy was Applied Digital: 774,423 shares worth $7.24M.
- EAM Investors added most to Arlo Technologies in Q2 2023, an estimated $2.35M increase.
- EAM Investors's biggest Q2 2023 reduction was Harrow, cutting an estimated $5.57M.
- EAM Investors fully exited Viking Therapeutics in Q2 2023, selling an estimated $5.66M.
- EAM Investors's ten largest holdings make up 9.8% of its $540M portfolio in Q2 2023.
- EAM Investors opened 161 new positions and closed 149 in Q2 2023.
- EAM Investors's portfolio value rose 6% quarter-over-quarter to $540M.
Based on EAM Investors's 13F filing for Q2 2023, filed 11 Aug 2023.